KelSie Biotech is Drug Delivery in United States that focus on delivery methods business. Founded in 2017. They cover business area such as developer, bioavailability delivery method, drug, sensitive active Pharmaceutical Ingredients, api, dry powder inhalable product, patented technology, bubble dry process, sublingual wafer, doctor, everyday dosage, patient, any difficulty.
2017
( 7 years old in 2024 )
Delivery Methods
-
3465 South Gaylord Court
Suite A316
Englewood, CO 80113
United States
Private
developerbioavailability delivery methoddrugsensitive active Pharmaceutical Ingredientsapidry powder inhalable productpatented technologybubble dry processsublingual waferdoctoreveryday dosagepatientany difficulty
* We use standard office opening hours in near KelSie Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
KelSie Biotech is Drug Delivery business from United States that founded in 2017 (7 years old in 2024), KelSie Biotech business is focusing on Delivery Methods.
KelSie Biotech headquarter office and corporate office address is located in 3465 South Gaylord Court Suite A316 Englewood, CO 80113 United States.
KelSie Biotech was founded in United States.
In 2024, KelSie Biotech is currently focus on delivery methods sector.
Above is snippet of Google Trends for "delivery methods" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with KelSie Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
